Why We Need Research

The media rarely mentions it, and public awareness fails unless a celebrity has it, or dies from it. It generally gets overlooked for funding compared to the more predominant cancers. People who get it generally don’t know they have it because it travels with much stealth around the body. Typically the first sign of the cancer is a mysterious bone fracture. Younger people are being diagnosed with myeloma. So what can we do as a patient group?

In 2010, the Myeloma Alberta Support Society embarked on an initiative “Multiple Miles for Myeloma” (MM4M) to raise funds specifically for myeloma research, at same time generating more awareness of the disease.  The committee was structured from our members and was chaired and lead by George Campsal (patient), who took our society into uncharted waters on this first event to which all proceeds went to myeloma research right here in Edmonton.  To date more than $700,000 has been raised and donated directly to the U of  A and the Cross Cancer Institute for Myeloma research.

100% of all money donated to Myeloma Alberta Support Society are donated through the University of Alberta to Myeloma Research at the University of Alberta and the Cross Cancer Institute.

2018 Fund Raisers for Myeloma Alberta Support Society

“Multiple Miles for Myeloma July21st. This event will be the  9th annual MM4M.  In past years, we have have over 250 participants and have typically raised over $80,000.  Please plan to participate and/or volunteer to help out at this event.


New Developments/Drugs in Treatment of Myeloma


Recent Articles

New Weapons in the Fight Against Multiple Myeloma” documented in a recent (Jan 4, 2106) All Street Journal article to read this interesting and informative article.
Read full article.

Tom Brokaw’s MBC interview (May 17, 2015) regarding his Multiple Myeloma Diagnosis, treatment and current status can be found.

Watch interview.

myeloma-absupport-society-logoDr. Belch (Dec. 17, 2014) Ross Neitz writes how Dr. Andrew Belch, professor of Medical Oncology at the University of Alberta and hematologist with the Cross Cancer Institute, and Myeloma Clinical Trials in Edmonton are helping to change global standards.
Read full article.

Patient Care Input